Turkish Journal of Hematology Volume: 37 Issue: 1 / 2020

Demiröz AS, et al: Blastic Plasmacytoid Dendritic Cell Neoplasia: A Single Center Experience Turk J Hematol 2020;37:48-52
References
1. Adachi M, Maeda K, Takekawa M, Hinoda Y, Imai K, Sugiyama S, Yachi A.
High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive
Lymphoma. Am J Hematol 1994;47:278-282.
2. Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of
Tumours of Haematopoietic and Lymphoid Tissues, 3th ed. Lyon France:
IARC Press; 2008. p. 146-147.
3. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, (Eds.)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. In
World Health Organization Classification of Tumours, 4th ed.; International
Agency for Research on Cancer: Lyon, France, 2017.
4. Sapienza MR, Pileri A, Derenzini E, Melle F, Motta G, Fiori S, Calleri A,
Pimpinelli N, Tabanelli V, Pileri S. Blastic plasmacytoid dendritic cell
neoplasm: state of the art and prospects. Cancers (Basel) 2019;11.
5. Julia F, Dalle S, Duru G, Balme B, Vergier B, Ortonne N, Vignon-Pennamen MD,
Costes-Martineau V, Lamant L, Dalac S, Delattre C, Déchelotte P, Courville
P, Carlotti A, De Muret A, Fraitag S, Levy A, Mitchell A, Petrella T. Blastic
plasmacytoid dendritic cell heoplasms. Am J Surg Pathol 2014;38:673-680.
6. Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne
AS, Jaffe ES. Blastic plasmacytoid dendritic cell neoplasm in children :
diagnostic features and clinical implications. Haematologica 2010;95:1873-
1879.
7. Nizza D, Simoneaux SF. Blastic plasmacytoid dendritic cell neoplasm
presenting as a subcutaneous mass in an 8-year-old boy. Pediatr Radiol
2010;40 Suppl 1:S40-42.
8. Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P,
Dereure O, Wetterwald M, d’Incan M, Grange F, Cornillon J, Tertian G,
Maubec E, Saiag P, Barete S, Templier I, Aubin F, Dalle S. Blastic plasmacytoid
dendritic cell neoplasm : clinical features in 90 patients. Br J Dermatol
2013;169:579-586.
9. Murphy N, Owens D, Hinds E, Nelson N. Blastic plasmacytoid dendritic cell
neoplasm (BPDCN) in leukaemic phase without skin lesions: a diagnostic
and management challenge. Pathology 2019;51:439-441.
10. Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M,
Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin
A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D’Incan M,
Wechsler J, Teitell MA. Blastic NK-cell lymphomas (agranular CD4+CD56+
hematodermic neoplasms): a review. Am J Clin Pathol 2005;123:662-675.
11. Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells. Adv Anat
Pathol 2009;16:392-404.
12. Feuillard J. Clinical and biologic features of CD4+CD56+ malignancies.
Blood 2002;99:1556-1563.
13. Shi Y, Wang E. Blastic plasmacytoid dendritic cell neoplasm: A
clinicopathologic review. Arch Pathol Lab Med 2014;138:564-569.
14. Petrella T, Comeau MR, Maynadié M, Couillault G, De Muret A, Maliszewski
CR, Dalac S, Durlach A, Galibert L. “Agranular CD4+ CD56+ hematodermic
neoplasm” (blastic NK-cell lymphoma) originates from a population of
CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol
2002;26:852-862.
15. Osaki Y, Yokohama A, Saito A, Tahara K, Yanagisawa K, Ogawa Y, Ishizaki T,
Mitsui T, Koiso H, Takizawa M, Uchiumi H, Saitoh T, Handa H, Murakami H,
Tsukamoto N, Nojima Y. Characterization of CD56+ dendritic-like cells: a
normal counterpart of blastic plasmacytoid dendritic cell neoplasm? PLoS
One 2013;8:e81722.
16. Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadié M, Machet L, Casasnovas
O, Vergier B, Teitell MA. TCL1 and CLA expression in agranular CD4/CD56
hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
Am J Clin Pathol 2004;122:307-313.
17. Ascani S, Massone C, Ferrara G, Rongioletti F, Papini M, Pileri S, Cerroni L.
CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: Description
of three cases. J Cutan Pathol 2008;35:911-915.
18. Cota C, Vale E, Viana I, Requena L, Ferrara G, Anemona L, Metze D, Fink-
Puches R, Wiesner T, Cerroni L. Cutaneous manifestations of blastic
plasmacytoid dendritic cell neoplasm - morphologic and phenotypic
variability in a series of 33 patients. Am J Surg Pathol 2010;34:75-87.
19. Weaver J, Hsi ED CD4+/CD56+ hematodermic neoplasm (blastic NK-cell
lymphoma). J Cutan Pathol 2008;35:975-977.
20. Petrella T, Facchetti F. Tumoral aspects of plasmacytoid dendritic cells: what
do we know in 2009? Autoimmunity 2010;43:210-214.
21. Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, Hollowood
K, Dictor M, Hansmann ML, Pileri SA, Dyer MJ, Sozzani S, Dikic I, Shaw
AS, Petrella T, Stein H, Isaacson PG, Facchetti F, Mason DY. Novel markers
of normal and neoplastic human plasmacytoid dendritic cells. Blood
2008;111:3778-3792
22. Kim HS, Kim HJ, Kim SH, Choi JY, Ko YH, Kim WS, Jung CW, Kim SJ. Clinical
features and treatment outcomes of blastic plasmacytoid dendritic cell
neoplasm: a single-center experience in Korea. Korean J Intern Med
2017;32:890-899.
23. Pagano L, Valentini CG, Grammatico S, Pulsoni A. Blastic plasmacytoid
dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.
Br J Haematol 2016;174:188–202.
24. Aoki T, Suzuki R, Kuwatsuka Y, Kako S, Fujimoto K, Taguchi J, Kondo
T, Ohata K, Ito T, Kamoda Y, Fukuda T, Ichinohe T, Takeuchi K, Izutsu K,
Suzumiya J. Long-term survival following autologous and allogeneic stem
cell transplantation for blastic plasmacytoid dendritic cell neoplasm. Blood
2015;125:3559-3562.
25. Riaz W, Zhang L, Horna P, Sokol L. Blastic plasmacytoid dendritic cell
neoplasm: update on molecular biology, diagnosis, and therapy. Cancer
Control 2014;21:279-289.
52